Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (291-300 of 443) with videos related to

Pageof 45
Sort By:
Journal of Hematology & Oncology|May 29, 2021
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMTJaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Hemasphere|November 15, 2019
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study GroupAlice Marceau-Renaut, Nicolas Duployez, Benoît Ducourneau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2018
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated DonorsRémy Duléry, Anne-Lise Ménard, Sylvain Chantepie, et al.
Bone Marrow Transplantation|November 25, 2020
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Transplantation and Cellular Therapy|May 9, 2021
Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working CommitteeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|May 4, 2021
Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|November 2, 2019
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignanciesZinaida Peric, Razan Mohty, Juliana Bastos, et al.
Annals of Hematology|March 21, 2009
Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent yearsSebastian Giebel, Myriam Labopin, Jerzy Holowiecki, et al.
British Journal of Haematology|November 24, 2018
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMTChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Journal of Hematology & Oncology|January 26, 2017
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working PartyMarie Thérèse Rubio, Maud D'Aveni-Piney, Myriam Labopin, et al.
Pageof 45

Showing results (291-300 of 443) with videos related to

Sort By:
Pageof 45
Journal of Hematology & Oncology|May 29, 2021
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMTJaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Hemasphere|November 15, 2019
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study GroupAlice Marceau-Renaut, Nicolas Duployez, Benoît Ducourneau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2018
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated DonorsRémy Duléry, Anne-Lise Ménard, Sylvain Chantepie, et al.
Bone Marrow Transplantation|November 25, 2020
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Transplantation and Cellular Therapy|May 9, 2021
Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working CommitteeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|May 4, 2021
Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|November 2, 2019
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignanciesZinaida Peric, Razan Mohty, Juliana Bastos, et al.
Annals of Hematology|March 21, 2009
Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent yearsSebastian Giebel, Myriam Labopin, Jerzy Holowiecki, et al.
British Journal of Haematology|November 24, 2018
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMTChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Journal of Hematology & Oncology|January 26, 2017
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working PartyMarie Thérèse Rubio, Maud D'Aveni-Piney, Myriam Labopin, et al.
Pageof 45